Dexco posted a net loss of R$ 48.3 million ($9M) in Q4 2025, reversing a R$ 22.3 million profit a year earlier, after R$ 84.7 million ($16M) in non-recurring charges — primarily impairment write-downs in its troubled Ceramic Tiles division — overwhelmed an otherwise improving operating performance.
Stripping out non-recurring items, recurring net income was R$ 36.4 million ($7M), a reversal from the R$ 83.6 million loss in Q4 2024, while adjusted and recurring EBITDA rose 12% to R$ 416.4 million ($80M) with margin expanding 1.9 percentage points to 19.9%.
Volumes declined across all three divisions — Deca metals and sanitary ware fell 20.8%, Ceramic Tiles dropped 4.2%, and Wood Panels dipped 1.1% — yet consolidated revenue still edged up 1.6% to R$ 2.01 billion ($385M) on pricing gains, particularly in wood.
What Happened at Dexco in Q4 2025
What Happened
Dexco S.A. (B3: DXCO3) — the Brazilian building-materials group behind brands including Deca, Portinari, Hydra, Duratex, and Castelatto — reported a net loss of R$ 48.3 million ($9M) for the fourth quarter of 2025. This reversed the R$ 22.3 million profit posted in Q4 2024 and capped a year that saw the company swing from R$ 22.4 million in full-year net income in 2024 to an annual loss.
The reported loss was shaped by R$ 84.7 million ($16M) in non-recurring charges, driven primarily by impairment write-downs on products in the Ceramic Tiles division — which is undergoing a major restructuring — along with unusual operating costs. These were partially offset by gains from the sale of non-operational real estate and fiscal credits.
On a recurring basis, the picture was markedly different. Recurring net income reached R$ 36.4 million ($7M), a turnaround from the R$ 83.6 million recurring loss a year earlier. Adjusted and recurring EBITDA climbed 12% year-over-year to R$ 416.4 million ($80M), with the margin expanding 1.9 percentage points to 19.9%.
Key Drivers Behind Dexco’s Q4 2025 Results
Key Drivers
Volume Declines and Revenue Resilience
The most striking disconnect in the quarter was between volumes and revenue. Dexco saw shipped volumes fall across all three divisions: Deca (metals and sanitary ware) dropped a sharp 20.8%, Ceramic Tiles declined 4.2%, and Wood Panels — the company’s strongest segment — dipped 1.1%. Yet consolidated revenue still grew 1.6% to R$ 2.01 billion ($385M).
The revenue growth despite universal volume declines was driven by pricing gains, particularly in wood panels, where favorable wood-price dynamics and disciplined competition allowed the company to pass through increases. Dexco described the competitive environment as featuring “high competitiveness and pressure on prices and volumes,” suggesting the balance is fragile.
Ceramic Tiles Impairment and Restructuring
The Ceramic Tiles division remains Dexco’s biggest operational headache. The division contributed the bulk of the R$ 84.7 million in non-recurring charges through asset impairments, reflecting a multi-year restructuring that management has described as necessary to right-size capacity to demand. The tiles sector experienced a roughly 30% volume collapse in 2022–2023, and recovery has been slow.
Management has previously indicated that the tiles turnaround will require a “new footprint, a new production volume” over 2026, and that the recovery will be gradual. Analysts at Goldman Sachs have projected that the Deca and ceramics segments together may deliver near-zero or negative EBITDA in 2025, with only single-digit margins expected by 2026.
Forest Revaluation and Non-Cash Effects
A notable positive within the non-cash items was a R$ 207.1 million ($40M) revaluation gain on Dexco’s forest inventory used for panel production, driven by higher wood prices. This partially offset the negative accounting adjustments, contributing to the total R$ 174.1 million in positive “extraordinary events” reported on the income statement.
The interplay between the R$ 204.9 million in negative “non-cash adjustments” and R$ 174.1 million in positive extraordinary items illustrates the complexity of Dexco’s reported results. The forest revaluation, while a genuine economic gain, does not generate cash and can reverse if wood prices decline.
Dexco’s Q4 2025 Financial Detail
Financial Detail
Cost Pressure and Financial Expenses
Cost of goods sold rose 10.2% to R$ 1.4 billion ($268M), driven by lower fixed-cost dilution from reduced volumes and impairment charges in the ceramics division. The EBITDA reported (non-adjusted) of R$ 448.2 million ($86M) fell 5.7%, with the margin contracting 1.6 percentage points to 21.4%.
Financial expenses ballooned 42.4% year-over-year to R$ 222.5 million ($43M), reflecting both the elevated Selic rate environment and Dexco’s high debt load. Goldman Sachs estimates that net financial expenses will remain between R$ 820–850 million annually in 2025–2026, consuming 50–60% of EBITDA — a punishing ratio for a company in restructuring mode.
Leverage and Cash Flow
Net debt declined 1.2% quarter-over-quarter to R$ 5.51 billion ($1.06B), and leverage improved to 3.35x from 3.48x in Q3, measured against adjusted annualized EBITDA. While the direction is positive, 3.35x remains elevated for an industrial company with cyclical earnings.
Free cash flow was negative at R$ 46.6 million ($9M), dragged down by higher working-capital consumption related to service improvements at Deca, inventory adjustments in ceramics, and supplier-payment restructuring. Sustaining capex of R$ 249.5 million ($48M) was 8.1% lower year-over-year, while project capex of R$ 270.9 million ($52M) reflects the tail end of the 2021–2025 investment cycle.
Management Signals from Dexco
Dexco’s management framed the quarter around the distinction between reported and recurring results, emphasizing that the R$ 84.7 million non-recurring charge was tied to a deliberate restructuring of the ceramics business rather than an operating deterioration. The company reaffirmed its commitment to “rentabilizing projects and driving value creation.”
In the Q3 earnings call, CEO Raul conveyed “urgency” in taking strategic action, with the company pursuing a five-pillar transformation plan: financial deleveraging, go-to-market improvements, a tiles turnaround, wood innovation, and Deca competitiveness. The Q4 results show early progress on deleveraging (3.35x vs 3.48x) and recurring profitability, but the tiles recovery remains nascent.
The R$ 207.1 million forest revaluation gain highlights what management has called Dexco’s “biggest strength” — its forest assets. Standing wood prices have remained elevated, providing a valuation cushion and supporting the outlook for both the wood panels business and the LD Celulose joint venture.
What to Watch Next for Dexco
What to Watch Next
The ceramic tiles restructuring timeline is the most critical variable. Management has signaled that a “new footprint” with right-sized production capacity should take shape over 2026, but the division has been loss-making for multiple quarters and any delays would extend the drag on consolidated results and cash flow.
LD Celulose — Dexco’s joint venture in dissolving pulp — could become a dividend contributor in 2026. The venture achieved record revenue and EBITDA in 2024 and has been operating above its nameplate capacity. If dividends materialize, they would provide a direct cash injection that could accelerate deleveraging.
Dexco recently approved a R$ 1 billion capital increase with share bonification, signaling balance-sheet repair is a priority. The end of the 2021–2025 investment cycle should reduce capex intensity going forward, freeing cash for debt reduction.
Ureia (urea) prices — a key input for adhesives in wood panel production — have risen roughly 42% versus early 2025 levels amid Middle East tensions. Goldman Sachs estimates this could reduce EBITDA by up to 15% if sustained, creating a significant cost headwind for 2026 in what is otherwise Dexco’s best-performing division.
Dexco Key Figures Q4 2025
| Metric | Q4 2025 | Q4 2024 | YoY Chg |
|---|---|---|---|
| Net Revenue | R$ 2.01B ($385M) | R$ 1.98B | +1.6% |
| Adj. & Recurring EBITDA | R$ 416M ($80M) | R$ 372M | +12.0% |
| Adj. EBITDA Margin | 19.9% | 18.0% | +1.9 pp |
| EBITDA (Reported) | R$ 448M ($86M) | R$ 475M | −5.7% |
| Net Income (Loss) | R$ −48M ($−9M) | R$ 22M | Reversal |
| Recurring Net Income | R$ 36M ($7M) | R$ −84M | Reversal |
| Net Financial Expense | R$ −223M ($−43M) | R$ −156M | +42.4% |
| Net Debt | R$ 5.51B ($1.06B) | — | −1.2% QoQ |
| Net Debt / Adj. EBITDA | 3.35x | 3.48x (Q3) | −0.13x |
Key Risks for Dexco Going Forward
Risks
Leverage remains dangerously high for the cycle. At 3.35x net debt-to-EBITDA and a 15% Selic rate, financial expenses are consuming more than half of operating earnings. Goldman Sachs projects slow deleveraging, with the ratio declining only to roughly 3.9x by end-2026 on a lease-adjusted basis, leaving minimal margin for error if construction-sector demand weakens further.
The ceramics turnaround is far from assured. The division has absorbed repeated write-downs and volume declines since 2022, and the market environment — shaped by tighter credit, high interest rates, and consumer caution — is not conducive to a rapid recovery. Any further impairments would extend the pattern of reported losses masking underlying operational gains.
Input-cost inflation in the wood panels business — particularly the 42% surge in urea prices — threatens the segment that has been Dexco’s reliable earnings engine. If the cost increase is sustained, it could erode margins in the division that currently subsidizes the rest of the group.
The Deca metals and sanitary ware division saw a 20.8% volume drop in Q4, likely reflecting both planned maintenance shutdowns and the broader slowdown in Brazil’s construction sector under restrictive monetary policy. If the Selic rate remains at or above 15% through 2026, credit-dependent demand for building materials will remain suppressed.
Sector Context for Brazil’s Building Materials Industry
Brazil’s building-materials sector is navigating a difficult cycle. The Selic rate at 15% has tightened mortgage credit and dampened residential construction activity, with the Brazilian Construction Chamber (CBIC) reporting more cautious expectations and a concentration of new launches in the lower-income Minha Casa Minha Vida segment — where Dexco’s premium finishes brands have limited penetration.
Dexco operates across three segments: Wood Panels (the strongest, with margins above capital cost), Metals and Sanitary Ware under the Deca brand (recovering but facing planned shutdowns), and Ceramic Tiles (under restructuring). The company also holds a stake in the LD Celulose dissolving-pulp joint venture, which has become a quiet value driver with above-capacity production and the potential for 2026 dividend distributions.
Analyst consensus leans constructive despite the challenges. The average 12-month price target is approximately R$ 7.00, implying roughly 32% upside from the current share price of around R$ 5.30. Citi rates Buy with a R$ 8.50 target, Morgan Stanley holds Equalweight at R$ 6.50, and Goldman Sachs is Neutral at R$ 6.00 — the latter flagging that the stock’s 6.8x 2026 EV/EBITDA sits 11% below its 10-year average but with limited catalysts to close the gap. DXCO3 has declined roughly 9% over the past twelve months.